Enanta Pharmaceuticals Inc SEC filings ENTA
Enanta Pharmaceuticals Inc has 835 filings in SEC EDGAR's recent list, going back to Jun 21, 2002. Its latest annual report, Form ARS, was filed on Jan 26, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 2, 2026 | — |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| S-3 | Shelf registration | Feb 11, 2026 | — |
| 424B5 | Prospectus supplement | Oct 1, 2025 | — |
| 424B5 | Prospectus supplement | Sep 30, 2025 | — |
| S-8 | Employee stock plan registration | May 14, 2025 | — |
| S-8 | Employee stock plan registration | May 8, 2024 | — |
| S-3 | Shelf registration | Nov 22, 2023 | — |
| S-8 | Employee stock plan registration | Aug 8, 2023 | — |
| 424B5 | Prospectus supplement | Aug 26, 2022 | — |
| S-8 | Employee stock plan registration | May 9, 2022 | — |
| S-3ASR | Automatic shelf registration | Aug 9, 2021 | — |
| S-8 | Employee stock plan registration | May 10, 2021 | — |
| S-8 | Employee stock plan registration | May 10, 2019 | — |
| S-8 | Employee stock plan registration | May 10, 2019 | — |
| S-8 | Employee stock plan registration | Dec 11, 2017 | — |
| S-8 | Employee stock plan registration | Dec 9, 2016 | — |
| S-8 | Employee stock plan registration | Feb 16, 2016 | — |
| S-8 | Employee stock plan registration | Feb 24, 2015 | — |
| S-8 | Employee stock plan registration | Dec 18, 2013 | — |
| S-8 | Employee stock plan registration | Jun 10, 2013 | — |
| 424B4 | Prospectus | Mar 21, 2013 | — |
| S-1/A | Amended registration statement | Mar 14, 2013 | — |
| S-1/A | Amended registration statement | Mar 5, 2013 | — |
| S-1/A | Amended registration statement | Feb 5, 2013 | — |
| S-1/A | Amended registration statement | Dec 18, 2012 | — |
| S-1/A | Amended registration statement | Nov 16, 2012 | — |
| S-1 | Registration statement | Nov 6, 2012 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ENTA (Nasdaq)
- Fiscal year ends
- September 30
- Headquarters
- Watertown, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1177648
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.